Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07190469 · ClinicalTrials.gov registry record · Phase 1

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

A Phase 1 study of Triple Negative Breast Cancer (TNBC) and Advanced Solid Tumors Cancer, sponsored by ProteinQure.

Recruiting
Registry status
Phase 1
Development phase
80
Enrollment target
4
Study locations

NCT07190469 is a Phase 1 study of Triple Negative Breast Cancer (TNBC) and Advanced Solid Tumors Cancer that is actively recruiting participants, run by ProteinQure. The registered enrollment target is 80 participants, below the 153-participant average among 14 other Triple Negative Breast Cancer (TNBC) trials with a reported enrollment target (48% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07190469, a Phase 1 study of Triple Negative Breast Cancer (TNBC) and Advanced Solid Tumors Cancer, is actively recruiting participants, sponsored by ProteinQure.

RECRUITING
Registry status
Phase 1
Development phase
80 participants
Enrollment target
4
Study locations

Study Summary

The primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breast cancer (TNBC), and to determine a recommended Phase 2 dose level for future studies in TNBC.

Conditions Studied

Triple Negative Breast Cancer (TNBC) Advanced Solid Tumors Cancer

Interventions

  • DRUG PQ203

Study Locations (4)

Texas

  • MD Anderson Cancer Center - Houston
  • NEXT Oncology - San Antonio

Utah

  • START Mountain Region - West Valley City

Ontario

  • Princess Margaret Cancer Centre - Toronto

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-09-16
Est. Completion 2029-02
Phase Phase 1

Sponsor

ProteinQure

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07190469

The ClinicalTrials.gov registry entry for NCT07190469 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 153-participant average among 14 other Triple Negative Breast Cancer (TNBC) trials with a reported enrollment target (48% lower). The listed sponsor is ProteinQure, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Triple Negative Breast Cancer (TNBC) appearing as the primary indexed condition, and to 1 intervention - of which PQ203 is the first listed.

NCT07190469 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Texas, Utah, Ontario.

Frequently Asked Questions

What is clinical trial NCT07190469 about?

NCT07190469 is a clinical study titled "PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer". The primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breast cancer (TNBC), and to determine a recommended Phase 2 dose level for future studies in TNBC.

What is the current status of trial NCT07190469?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2025-09-16. Estimated completion is 2029-02.

What conditions does trial NCT07190469 study?

This clinical trial studies the following conditions: Triple Negative Breast Cancer (TNBC), Advanced Solid Tumors Cancer.

What interventions are being tested in trial NCT07190469?

The interventions under investigation include: PQ203 (DRUG).

Who is sponsoring clinical trial NCT07190469?

This trial is sponsored by ProteinQure, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07190469 being conducted?

This trial has 4 study locations across Texas, Utah, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Triple Negative Breast Cancer (TNBC)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Triple Negative Breast Cancer (TNBC)

All registered trials for this condition

Advanced Solid Tumors Cancer

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.